Literature DB >> 33763818

Psychological Issues and Sexual Function in Women with Different Infertility Causes: Focus on Polycystic Ovary Syndrome.

Iuliia Naumova1,2, Camil Castelo-Branco3, Gemma Casals1.   

Abstract

The objectives of this study are to assess the prevalence of psychological complaints and changes in sexual function in infertile PCOS women compared with patients with other infertility causes (tubal and male infertility factors) and to identify the predisposing factors. An observational study with three cohorts of infertile women was designed including 37 PCOS patients, 36 women with tubal factor, and 31 women with male factor. Clinical history and physical examination were carried out in all patients. All subjects completed the Hamilton Anxiety Rating Scale, the Beck Depression Inventory, and the Female Sexual Function Index questionnaires. Women with infertility due to PCOS showed a significantly higher prevalence of depressive (48.6 vs 19.4 and 12.9%, p < 0.01) and anxiety symptoms (21.6 vs 5.6 and 3.2%, p = 0.041) than respondents of reference groups. Sexual function in PCOS subjects was impaired in the areas orgasm and satisfaction (p < 0.01 for both) compared to patients of reference groups. Clinical, biochemical hyperandrogenism, and overweight were associated with a higher incidence of depressive and anxiety symptoms in the infertile PCOS group (p < 0.01 for all). Besides, the severity of anxiety symptoms was associated with the number of medically assisted reproduction attempts (p = 0.014). Weight gain and age (p = 0.04 and p = 0.047) were associated with impaired sexual functioning. The relation between reduced sexuality and depressive/anxiety symptoms was found (p = 0.038 and p = 0.012, respectively). Infertile PCOS patients showed the highest prevalence of psychological complaints and some impairment in their sexual functioning. Mental health and sexual functioning need to be part of the routine clinical screening of every PCOS patient. The study was registered at clinicaltrials.gov (identifier: NCT03306459) https://clinicaltrials.gov/ct2/show/NCT03306459?cond=PCOS&cntry=ES&city=Barcelona&draw=2&rank=3.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Anxiety; Depression; Infertility; PCOS; Sexual functioning

Mesh:

Year:  2021        PMID: 33763818     DOI: 10.1007/s43032-021-00546-x

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  33 in total

1.  Quality of life and sexual function in women with polycystic ovary syndrome: a comprehensive review.

Authors:  Camil Castelo-Branco; Iuliia Naumova
Journal:  Gynecol Endocrinol       Date:  2019-09-27       Impact factor: 2.260

2.  [The prevalence of common mental disorders in the population of adult Poles by sex and age structure - an EZOP Poland study].

Authors:  Andrzej Kiejna; Patryk Piotrowski; Tomasz Adamowski; Jacek Moskalewicz; Jacek Wciórka; Jakub Stokwiszewski; Daniel Rabczenko; Ronald Kessler
Journal:  Psychiatr Pol       Date:  2015 Jan-Feb       Impact factor: 1.657

Review 3.  Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Anuja Dokras; Shari Clifton; Walter Futterweit; Robert Wild
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

4.  Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors.

Authors:  Lidia Borghi; Daniela Leone; Elena Vegni; Valentina Galiano; Corina Lepadatu; Patrizia Sulpizio; Emanuele Garzia
Journal:  J Psychosom Obstet Gynaecol       Date:  2017-04-06       Impact factor: 2.949

Review 5.  Mood disorders and quality of life in polycystic ovary syndrome.

Authors:  Agnieszka Podfigurna-Stopa; Stefano Luisi; Cristina Regini; Krzysztof Katulski; Gabriele Centini; Blazej Meczekalski; Felice Petraglia
Journal:  Gynecol Endocrinol       Date:  2015-07-23       Impact factor: 2.260

6.  Quality of life and psychological well being in polycystic ovary syndrome.

Authors:  L Barnard; D Ferriday; N Guenther; B Strauss; A H Balen; L Dye
Journal:  Hum Reprod       Date:  2007-05-30       Impact factor: 6.918

7.  Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome.

Authors:  Angelika Stapinska-Syniec; Klaudia Grabowska; Monika Szpotanska-Sikorska; Bronislawa Pietrzak
Journal:  Gynecol Endocrinol       Date:  2018-01-16       Impact factor: 2.260

8.  Disturbed stress responses in women with polycystic ovary syndrome.

Authors:  S Benson; P C Arck; S Tan; S Hahn; K Mann; N Rifaie; O E Janssen; M Schedlowski; S Elsenbruch
Journal:  Psychoneuroendocrinology       Date:  2009-01-15       Impact factor: 4.905

9.  Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.

Authors:  Angela Kerchner; Whitney Lester; Scott P Stuart; Anuja Dokras
Journal:  Fertil Steril       Date:  2008-02-04       Impact factor: 7.329

10.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Authors:  Neil F Goodman; Rhoda H Cobin; Walter Futterweit; Jennifer S Glueck; Richard S Legro; Enrico Carmina
Journal:  Endocr Pract       Date:  2015-11       Impact factor: 3.443

View more
  2 in total

1.  microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

Authors:  Yi-Xuan Wu; Yan-Shan Lin; Si-Chen Li; Xi Yao; Mingwei Cheng; Lin Zhu; Hai-Ying Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-11-23       Impact factor: 5.211

2.  Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study.

Authors:  Fatemeh Bahadori; Shahideh Jahanian Sadatmahalleh; Ali Montazeri; Malihe Nasiri
Journal:  BMC Womens Health       Date:  2022-09-25       Impact factor: 2.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.